14:26 11/02/2016 Trending Stocks: Synta Pharmaceuticals Corp. (SNTA), Arena Pharmaceuticals ...
Trending Stocks: Synta Pharmaceuticals Corp. (SNTA), Arena Pharmaceuticals ...
News Oracle - 8 hours ago
The company's RSI reading has hit 27.33. The stock edged lower by -3.11% to close previous trading session at USD 0.190.

11:26 11/02/2016 Price Target Update On Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
Price Target Update On Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
Risers & Fallers - 11 hours ago
A number of investment brokers have recently updated their price targets on shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA).

20:37 10/02/2016 Analyst Review Alert: Arena Pharmaceuticals, Inc. (ARNA)
Analyst Review Alert: Arena Pharmaceuticals, Inc. (ARNA)
CWRU Observer - Feb 10, 2016
Wall Street analysts have a much less favorable assessment of Arena Pharmaceuticals, Inc. (ARNA), with a mean rating of 2.7.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) PT & Analyst Recommendation Review - Uptick Analyst

22:34 04/02/2016 Arena Pharmaceuticals Inc. (ARNA) Jumps 9.66% on February 04
Arena Pharmaceuticals Inc. (ARNA) Jumps 9.66% on February 04
Equities.com - Feb 4, 2016
Arena Pharmaceuticals Inc. (ARNA) was among the biggest gainers on the Russell 2000 for Thursday February 04 as the stock popped 9.66% to $1.59, representing a gain of $0.14 per share.

16:30 04/02/2016 Analyst's Roundup: Arena Pharmaceuticals, Inc.
Analyst's Roundup: Arena Pharmaceuticals, Inc.
CWRU Observer - Feb 4, 2016
The shares of Arena Pharmaceuticals, Inc (NASDAQ:ARNA) currently has mean rating of 2.71 while 0 analysts have recommended the shares as “BUY”, 2 recommended as “OUTPERFORM” and 5 recommended as “HOLD”.
How Analysts Feel About Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)? - WallStreet.org
Hot Biotech Stocks To Watch Right Now – Inovio Pharmaceuticals, Inc. (INO ... - iStreetWire

20:26 02/02/2016 Arena Pharmaceuticals, Inc. (ARNA) Earns Hold Rating from Needham & Company LLC
Arena Pharmaceuticals, Inc. (ARNA) Earns Hold Rating from Needham & Company LLC
EMQ - Feb 2, 2016
Needham & Company LLC reiterated their hold rating on shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) in a research note issued to investors on Wednesday, MarketBeat Ratings reports.

18:45 28/01/2016 Arena Pharmaceuticals, Inc. (ARNA) Upgraded to Buy at Zacks Investment Research
Arena Pharmaceuticals, Inc. (ARNA) Upgraded to Buy at Zacks Investment Research
IRA Market Report - Jan 28, 2016
Arena Pharmaceuticals logo Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Thursday, AnalystRatings.
Technical Analysis: Arena Pharmaceuticals, Inc. - CWRU Observer
Arena Pharmaceuticals, Inc. (ARNA) Stock Rating Lowered by Zacks Investment ... - Corvus Business Newswire

15:47 26/01/2016 Biotech Beach: Needham Provides Updates on Gilead Sciences, Inc. (GILD), Arena ...
Biotech Beach: Needham Provides Updates on Gilead Sciences, Inc. (GILD), Arena ...
Smarter Analyst - Jan 26, 2016
The biotechnology sector is always volatile, and the recent market sell-off only makes it more so. Consequently, Alan Carr of Needham notes that it is best to focus on “commercial-stage or regulatory-stage companies with substantial cash reserves” at ...

23:48 21/01/2016 Zacks Investment Research Upgrades Arena Pharmaceuticals, Inc. (ARNA) to "Buy"
Zacks Investment Research Upgrades Arena Pharmaceuticals, Inc. (ARNA) to "Buy"
EMQ - Jan 21, 2016
Arena Pharmaceuticals logo Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Tuesday, Market Beat.
Short Interest in Arena Pharmaceuticals, Inc. (ARNA) Decreases By 22.6% - Corvus Business Newswire

0:00 16/01/2016 Arena Pharmaceuticals, Inc. (ARNA) Stock Rating Upgraded by Zacks Investment ...
Arena Pharmaceuticals, Inc. (ARNA) Stock Rating Upgraded by Zacks Investment ...
EMQ - Jan 16, 2016
Arena Pharmaceuticals logo Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Wednesday, ARN reports.
Boehringer Ingelheim, Arena Pharmaceuticals to research schizophrenia drug ... - Healio
Biotech Stock under consideration today: Arena Pharmaceuticals, Inc - iStreetWire